Phase II study of Gleevec® plus hydroxyurea in adults with progressive or recurrent low-grade glioma()

BACKGROUND: We evaluated the efficacy of imatinib plus hydroxyurea in patients with progressive/recurrent low-grade glioma. METHODS: A total of 64 patients with recurrent/progressive low-grade glioma were enrolled in this single-center study that stratified patients into astrocytoma and oligodendrog...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Reardon, David A., Desjardins, Annick, Vredenburgh, James J., Herndon, James E., Coan, April, Gururangan, Sridharan, Peters, Katherine B., McLendon, Roger, Sathornsumetee, Sith, Rich, Jeremy N., Lipp, Eric S., Janney, Dorothea, Friedman, Henry S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3748946/
https://ncbi.nlm.nih.gov/pubmed/22371319
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.26541
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados